Evidence map›Paper›PMID 38550316›Full record

ArticleFrontiers in public health2024

COVID-19 vaccination and the risk of autoimmune diseases: a Mendelian randomization study.

Jiayi Shan, Xiaoyun Hu, Tianzhu Chen, Yuyang Wang, Baoyi Huang, Yijun Xin, Hua Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jiayi Shan *The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaoyun Hu *Department of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Tianzhu ChenThe First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yuyang WangThe First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Baoyi HuangThe First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yijun XinThe First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, China.
Hua XuDepartment of Pediatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In recent times, reports have emerged suggesting that a variety of autoimmune disorders may arise after the coronavirus disease 2019 (COVID-19) vaccination. However, causality and underlying mechanisms remain unclear. Methods: We collected summary statistics of COVID-19 vaccination and 31 autoimmune diseases from genome-wide association studies (GWAS) as exposure and outcome, respectively. Random-effects inverse variance weighting (IVW), MR Egger, weighted median, simple mode, and weighted mode were used as analytical methods through Mendelian randomization (MR), and heterogeneity and sensitivity analysis were performed. Results: We selected 72 instrumental variables for exposure ( Conclusion: Our study provided potential evidence for the impact of COVID-19 vaccination on the risk of MS and UC occurrence, but it lacks sufficient robustness, which could provide a new idea for public health policy.

Indexed as

Autoimmune DiseasesColitis, UlcerativeCOVID-19COVID-19 VaccinesGenome-Wide Association StudyHumansMendelian Randomization AnalysisVaccinationCOVID-19 Vaccinesautoimmune diseasesCOVID-19COVID-19 vaccinationimmunityMendelian randomization studymultiple sclerosisulcerative colitisvaccination

Identifiers

PMID38550316
PMCPMC10973840
OpenAlexW4392812732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.